Drug Maker Had Duty To Disclose Clinical Trial Information, Investor Argues

Mealey's (April 12, 2022, 1:26 PM EDT) -- RICHMOND, Va. — A clinical-stage biopharmaceutical company and certain of its current and former senior executives are incorrect in contending that they had no duty to disclose certain data notwithstanding its...
To view the full article, register now.